|
I heard about the delisting but didn't they appeal? which extends the deadline to april 16?
probably reverse split to get its share over $1?
XOMA's product, XOMA 052 is undergoing its second phase of the FDA thing, if it gets partnership or approval... $$$$$
this is just my rambling, Im pretty noob with penny stock healthcare
|